A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors (NCT07263594)
A Phase 1/2, Multicenter, Open-Label, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1324 in Participants With Advanced/Metastatic Gastrointestinal Tumors
🩺 Plain-English Summary (8th-Grade Level)
This study, the first clinical trial, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of DB-1324.
Who can join: Review the eligibility criteria below.
Location: USA05-0 — Port Saint Lucie, Florida
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- USA05-0 — Port Saint Lucie, Florida
- USA02-0 — Grand Rapids, Michigan
- USA01-0 — Huntersville, North Carolina
- USA03-0 — Cincinnati, Ohio
- AUS02-0 — Randwick, New South Wales
- AUS03-0 — South Brisbane, Queensland
- AUS01-0 — Nedlands, Western Australia
- CHN01-0 — Beijing,
- CHN04-0 — Beijing,
📞 Contact the Study Coordinator
Phone: (412) 327-9868
Email: zhaochuan.wang@dualitybiologics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gastrointestinal Cancer
- Advancing Nursing Practices in Hospital Oncology Care — New York, New York
- Avatrombopag vs. Placebo for CIT in GI Malignancies — Miami, Florida
- A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005) — New Haven, Connecticut
- Dyadic Sleep Study — Coral Gables, Florida
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. — Cleveland, Ohio
- Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) — Los Angeles, California
Explore by condition: All Gastrointestinal Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.